Literature DB >> 26715602

When to re-dose regadenoson?

Gregory S Thomas1,2, Aaron F Jolly3,4, Michael Safani3,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26715602     DOI： 10.1007/s12350-015-0376-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  18 in total

1.  Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.

Authors:  Robert C Hendel; Timothy M Bateman; Manuel D Cerqueira; Ami E Iskandrian; Jeffrey A Leppo; Brent Blackburn; John J Mahmarian
Journal:  J Am Coll Cardiol       Date:  2005-11-09       Impact factor: 24.094

2.  Regadenoson pharmacokinetics and tolerability in subjects with impaired renal function.

Authors:  Toufigh Gordi; Brent Blackburn; Hsiao Lieu
Journal:  J Clin Pharmacol       Date:  2007-07       Impact factor: 3.126

3.  Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells.

Authors:  V Ramkumar; M E Olah; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1991-11       Impact factor: 4.436

Review 4.  Regadenoson.

Authors:  G M Bengalorkar; K Bhuvana; N Sarala; T N Kumar
Journal:  J Postgrad Med       Date:  2012 Apr-Jun       Impact factor: 1.476

5.  Desensitization of the stimulatory A2 adenosine receptor-adenylate cyclase system in vascular smooth muscle cells from rat aorta.

Authors:  M B Anand-Srivastava; M Cantin; M Ballak; S Picard
Journal:  Mol Cell Endocrinol       Date:  1989-04       Impact factor: 4.102

6.  Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.

Authors:  Manuel D Cerqueira; Patricia Nguyen; Peter Staehr; S Richard Underwood; Ami E Iskandrian
Journal:  JACC Cardiovasc Imaging       Date:  2008-05

7.  Role of arterial chemoreceptors in mediating the effects of endogenous adenosine on sympathetic nerve activity.

Authors:  E D Engelstein; B B Lerman; V K Somers; R F Rea
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

8.  Adenosine-5'-uronamides rapidly desensitize the adenosine A2 receptor in coronary artery.

Authors:  S R Makujina; S J Mustafa
Journal:  J Cardiovasc Pharmacol       Date:  1993-09       Impact factor: 3.105

9.  Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: potential for use in myocardial perfusion imaging.

Authors:  Jean-Noël Trochu; Gong Zhao; Heiner Post; Xiaobin Xu; Luiz Belardinelli; Francis L Belloni; Thomas H Hintze
Journal:  J Cardiovasc Pharmacol       Date:  2003-01       Impact factor: 3.105

10.  Safety and tolerability of intravenous regadenoson in healthy subjects: A randomized, repeat-dose, placebo-controlled study.

Authors:  Robert Townsend; Amit Desai; Diane Rammelsberg; Donna Kowalski; Neal Simmons; Therese M Kitt
Journal:  J Nucl Cardiol       Date:  2015-11-25       Impact factor: 5.952
View more
  3 in total

Review 1.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952

2.  Adenosine A2A Receptor Activation Enhances Blood-Tumor Barrier Permeability in a Rodent Glioma Model.

Authors:  Amélie Vézina; Monica Manglani; DreeAnna Morris; Brandon Foster; Matthew McCord; Hua Song; Meili Zhang; Dionne Davis; Wei Zhang; Jessica Bills; Kunio Nagashima; Priya Shankarappa; Jessica Kindrick; Stuart Walbridge; Cody J Peer; William D Figg; Mark R Gilbert; Dorian B McGavern; Leslie L Muldoon; Sadhana Jackson
Journal:  Mol Cancer Res       Date:  2021-09-14       Impact factor: 6.333

Review 3.  Modulation of Blood-Brain Barrier Permeability by Activating Adenosine A2 Receptors in Oncological Treatment.

Authors:  Kamila Wala; Wojciech Szlasa; Jolanta Saczko; Julia Rudno-Rudzińska; Julita Kulbacka
Journal:  Biomolecules       Date:  2021-04-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.